# Psychiatry Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Abraham Lincoln (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI001-SYN-TD
- Date: 1841-06-30
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elena Marquez, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Priya Natarajan, MD, Psychiatry
- Urgency: Routine; booked for the day of his six-week review. No current suicidal ideation

## Referral question

Moderate major depressive disorder, single episode, in a 32-year-old attorney starting sertraline 50 mg daily. Please confirm the diagnosis, look for bipolar spectrum illness, review his suicide risk and safety plan, and advise on medication management and psychotherapy. **S**

## Questions for the consultant

1. Do you agree with the diagnosis of a single, moderate, uncomplicated episode of major depressive disorder, and is there any sign of bipolar spectrum illness or another condition that would change treatment?
2. Is sertraline 50 mg daily an appropriate first choice, and when should the dose be increased?
3. Please review his suicide risk and the collaborative safety plan.
4. Would you add psychotherapy, and how long should treatment continue after remission?

## Pertinent history

Low mood, loss of interest, and poor sleep over several weeks are affecting his legal work and friendships, with reduced concentration and missed work. PHQ-9 14. No current suicidal ideation, intent, or plan; access to lethal means reviewed; collaborative safety plan with crisis resources, including the 988 Suicide & Crisis Lifeline, completed today. Protective factors: close friendships, a sense of purpose in public service, and engagement in treatment. No earlier depressive episode is documented. His mother died when he was nine and his older sister in his late teens. No tobacco or alcohol use; no known allergy. Sertraline 50 mg daily started today after shared decision-making; he prefers medication to psychotherapy. **S**

- Abraham Lincoln was born February 12, 1809, near what is now Hodgenville, Kentucky. **D**
- In 1859 Lincoln described himself as "six feet, four inches, nearly" in height. **D**
- In his tenth year Lincoln was kicked by a horse and, in his own account, "apparently killed for a time." **D**
- On January 23, 1841, Lincoln wrote to John T. Stuart, "I am now the most miserable man living." **D**
- Lincoln’s recurrent melancholy is retrospectively interpreted by modern clinicians as chronic depression that did not prevent him from leading the nation. **R**
- Lincoln’s mother, Nancy Hanks Lincoln, died of milk sickness on October 5, 1818, when he was nine. **D**
- Marfan syndrome, or another inherited marfanoid disorder such as multiple endocrine neoplasia type 2B, has been proposed retrospectively from Lincoln’s build; the diagnosis is disputed and has never been genetically confirmed. **R**
- Lincoln’s older sister, Sarah Lincoln Grigsby, died on January 20, 1828, at age twenty-one, from complications during delivery that also took her infant’s life. **D**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]: 14. All results are synthetic.

BP 118/74 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 82 kg; BMI 22 kg/m². All vital signs are synthetic.

## Current medications

- Sertraline 50 mg oral tablet, one tablet by mouth daily **S**

## Plan so far

- Use shared decision-making to choose monotherapy for uncomplicated major depression; patient prefers medication over psychotherapy. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
- Start sertraline 50 mg daily; review expected time to benefit, common adverse effects, and how to reach the clinic. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
- Repeat PHQ-9 at six and twelve weeks and adjust treatment if response is inadequate; plan continuation treatment after remission. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
- Create a collaborative safety plan with crisis resources, including the 988 Suicide & Crisis Lifeline. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
